INO-4201
2020-02774
Phase 1 mab completed
Quick answer
INO-4201 for Ebola Virus Disease is a Phase 1 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INOVIO PHARMACEUTICALS, INC.
- Indication
- Ebola Virus Disease
- Phase
- Phase 1
- Modality
- mab
- Status
- completed